Disc Medicine, Inc. (IRON)
57.04
+1.30
(+2.33%)
USD |
NASDAQ |
Oct 15, 10:04
Disc Medicine Net Income (Quarterly) : -59.53M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -59.53M |
| March 31, 2026 | -63.50M |
| December 31, 2025 | -60.53M |
| September 30, 2025 | -62.32M |
| June 30, 2025 | -55.25M |
| March 31, 2025 | -34.08M |
| December 31, 2024 | -29.46M |
| September 30, 2024 | -26.60M |
| June 30, 2024 | -26.35M |
| March 31, 2024 | -26.95M |
| December 31, 2023 | -23.58M |
| September 30, 2023 | -14.12M |
| June 30, 2023 | -15.95M |
| Date | Value |
|---|---|
| March 31, 2023 | -22.78M |
| December 31, 2022 | -21.23M |
| September 30, 2022 | -16.15M |
| June 30, 2022 | -9.58M |
| March 31, 2022 | -9.853M |
| December 31, 2021 | -17.82M |
| September 30, 2021 | -18.55M |
| June 30, 2021 | -16.45M |
| March 31, 2021 | -19.05M |
| December 31, 2020 | -14.32M |
| September 30, 2020 | -10.00M |
| June 30, 2020 | -6.773M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -131.00M |
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 59.53M |
| EPS Diluted (Quarterly) | -1.539 |
| Enterprise Value | 1.481B |
| Earnings Yield | -11.53% |
| Normalized Earnings Yield | -11.53 |